Study connects brain volume variations with genetic risk factors for Parkinson’s disease and ADHD

Unprecedented genome analysis reveals genetic links between brain structure and disorders like Parkinson’s and ADHD, paving the way for innovative treatments.

Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma

CHICAGO — Progression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf; Blenrep) combined with pomalidomide (Pomalyst) and dexamethasone (BPd), compared with standard-of-care pomalidomide, bortezomib

June 3, 2024

Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancer

Adding liposome-encapsulated irinotecan to standard chemotherapy failed to improve survival as second-line treatment for advanced biliary cancer, a small randomized study showed. Median progression-free survival

June 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Study connects brain volume variations with genetic risk factors for Parkinson’s disease and ADHD

Social media messages may sway young people’s beliefs about mental illness

Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma

Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancer

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe